Published in Clin Chem on June 01, 2001
LC-MS/MS in the Clinical Laboratory - Where to From Here? Clin Biochem Rev (2011) 1.36
Advances in biochemical screening for phaeochromocytoma using biogenic amines. Clin Biochem Rev (2009) 0.87
The genetic basis of pheochromocytoma and paraganglioma: implications for management. Urology (2014) 0.83
The role of urinary fractionated metanephrines in the diagnosis of phaeochromocytoma. Indian J Med Res (2013) 0.78
Sympathetic cardioneuropathy in dysautonomias. N Engl J Med (1997) 3.14
Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase. Clin Chem (1986) 2.95
Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions. Physiol Rev (1990) 2.48
Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma. Ann Intern Med (2001) 2.45
Improved assay for plasma dihydroxyphenylacetic acid and other catechols using high-performance liquid chromatography with electrochemical detection. J Chromatogr B Biomed Appl (1994) 2.13
Simultaneous measurements of cardiac noradrenaline spillover and sympathetic outflow to skeletal muscle in humans. J Physiol (1992) 1.97
Plasma metanephrines in the diagnosis of pheochromocytoma. Ann Intern Med (1995) 1.64
Haploinsufficiency of steroidogenic factor-1 in mice disrupts adrenal development leading to an impaired stress response. Proc Natl Acad Sci U S A (2000) 1.50
Determination of metanephrines in plasma by liquid chromatography with electrochemical detection. Clin Chem (1993) 1.47
6-[18F]fluorodopamine positron emission tomographic (PET) scanning for diagnostic localization of pheochromocytoma. Hypertension (2001) 1.45
Plasma dihydroxyphenylglycol and the intraneuronal disposition of norepinephrine in humans. J Clin Invest (1988) 1.41
Hyperleptinaemia does not correlate with plasma catecholamine levels in chronic heart failure. Eur Heart J (1999) 1.38
Increased cardiac adrenergic drive precedes generalized sympathetic activation in human heart failure. Circulation (1997) 1.29
Plasma levels of catechols and metanephrines in neurogenic orthostatic hypotension. Neurology (2003) 1.26
Adrenomedullary dysplasia and hypofunction in patients with classic 21-hydroxylase deficiency. N Engl J Med (2000) 1.24
Sympathetically mediated effects of mental stress on the cardiac microcirculation of patients with coronary artery disease. Am J Cardiol (1995) 1.22
Radiofrequency ablation: a novel approach for treatment of metastatic pheochromocytoma. J Natl Cancer Inst (2001) 1.19
Cardiac sympathetic nervous activity in congestive heart failure. Evidence for increased neuronal norepinephrine release and preserved neuronal uptake. Circulation (1993) 1.16
Metabolic stress in PC12 cells induces the formation of the endogenous dopaminergic neurotoxin, 3,4-dihydroxyphenylacetaldehyde. J Neurosci Res (2000) 1.16
Positron emission tomographic imaging of cardiac sympathetic innervation using 6-[18F]fluorodopamine: initial findings in humans. J Am Coll Cardiol (1993) 1.13
Catecholamine synthesis is mediated by tyrosinase in the absence of tyrosine hydroxylase. J Neurosci (1999) 1.12
Specific genetic deficiencies of the A and B isoenzymes of monoamine oxidase are characterized by distinct neurochemical and clinical phenotypes. J Clin Invest (1996) 1.09
Effects of desipramine on sympathetic nerve firing and norepinephrine spillover to plasma in humans. Am J Physiol (1991) 1.07
3,4-Dihydroxyphenylacetaldehyde potentiates the toxic effects of metabolic stress in PC12 cells. Brain Res (2000) 1.07
Effect of ethanol ingestion on plasma vasopressin and water balance in humans. Am J Physiol (1982) 1.06
Increased sympathetic nerve activity in renovascular hypertension. Circulation (1999) 1.06
The importance of adrenocortical glucocorticoids for adrenomedullary and physiological response to stress: a study in isolated glucocorticoid deficiency. J Clin Endocrinol Metab (2001) 1.04
Mechanism of peripheral noradrenergic stimulation by clozapine. Neuropsychopharmacology (1999) 1.04
Sources and physiological significance of plasma dopamine sulfate. J Clin Endocrinol Metab (1999) 1.02
[Radiation exposure of patients during 68Ga-DOTATOC PET/CT examinations]. Nuklearmedizin (2009) 1.02
Positron emission tomographic imaging of cardiac sympathetic innervation and function. Circulation (1990) 1.01
In vivo measurement of neuronal uptake of norepinephrine in the human heart. Circulation (1988) 0.98
Simultaneous determination of plasma noradrenaline and adrenaline kinetics. Responses to nitroprusside-induced hypotension and 2-deoxyglucose-induced glucopenia in the rabbit. Naunyn Schmiedebergs Arch Pharmacol (1990) 0.98
Expression of neuropeptide hormone receptors in human adrenal tumors and cell lines: antiproliferative effects of peptide analogues. Proc Natl Acad Sci U S A (2009) 0.95
Chromaffin cells: the peripheral brain. Mol Psychiatry (2012) 0.94
Regional extraction of circulating norepinephrine, DOPA, and dihydroxyphenylglycol in humans. J Auton Nerv Syst (1991) 0.93
Pheochromocytoma as a catecholamine producing tumor: implications for clinical practice. Stress (2007) 0.93
Positron emission imaging of cardiac sympathetic innervation and function using 18F-6-fluorodopamine: effects of chemical sympathectomy by 6-hydroxydopamine. J Hypertens (1991) 0.93
Adrenomedullary function is severely impaired in 21-hydroxylase-deficient mice. FASEB J (1999) 0.93
Cardiac norepinephrine kinetics in hypertrophic cardiomyopathy. Circulation (1989) 0.93
Chromaffin cell function and structure is impaired in corticotropin-releasing hormone receptor type 1-null mice. Mol Psychiatry (2002) 0.92
Low molecular weight proteomic information distinguishes metastatic from benign pheochromocytoma. Endocr Relat Cancer (2005) 0.92
Biochemical diagnosis, localization and management of pheochromocytoma: focus on multiple endocrine neoplasia type 2 in relation to other hereditary syndromes and sporadic forms of the tumour. J Intern Med (2005) 0.91
Deletion of tyrosine hydroxylase gene reveals functional interdependence of adrenocortical and chromaffin cell system in vivo. Proc Natl Acad Sci U S A (2000) 0.91
Sympathetic discharge to mesenteric organs and the liver. Evidence for substantial mesenteric organ norepinephrine spillover. J Clin Invest (1996) 0.91
Evidence for increased noradrenaline release from subcortical brain regions in essential hypertension. J Hypertens (1993) 0.90
Differential effects of chemical sympathectomy on expression and activity of tyrosine hydroxylase and levels of catecholamines and DOPA in peripheral tissues of rats. Neurochem Res (1999) 0.90
A "pheo" lurks: novel approaches for locating occult pheochromocytoma. J Clin Endocrinol Metab (2001) 0.89
Neuronal source of plasma dihydroxyphenylalanine. J Clin Endocrinol Metab (1987) 0.89
Plasma catecholamine responses to change of posture in alcoholics during withdrawal and after continued abstinence from alcohol. Clin Sci (Lond) (1985) 0.89
Mortality associated with phaeochromocytoma. Horm Metab Res (2013) 0.88
A novel nonneuronal catecholaminergic system: exocrine pancreas synthesizes and releases dopamine. Proc Natl Acad Sci U S A (1996) 0.88
Increased norepinephrine spillover into the jugular veins in essential hypertension. Hypertension (1992) 0.87
Effects of aldehyde/aldose reductase inhibition on neuronal metabolism of norepinephrine. J Auton Nerv Syst (1997) 0.87
Effects of ethanol on plasma catecholamines and norepinephrine clearance. Clin Pharmacol Ther (1983) 0.87
Effects of ethanol ingestion on alpha-adrenoceptor-mediated circulatory responses in man. Br J Clin Pharmacol (1984) 0.87
Non-neuronal dopamine in the gastrointestinal system. Clin Exp Pharmacol Physiol Suppl (1999) 0.86
Norepinephrine spillover from human adipose tissue before and after a 72-hour fast. J Clin Endocrinol Metab (2002) 0.85
Plasma norepinephrine responses to head-up tilt are misleading in autonomic failure. Hypertension (1992) 0.85
The effects of acute and chronic ingestion of ethanol on the autonomic nervous system. Drug Alcohol Depend (1986) 0.85
Biochemical evidence of sympathetic hyperactivity in human hypertension. Hypertension (1991) 0.85
Tyrosine hydroxylase assay for detection of low levels of enzyme activity in peripheral tissues. J Chromatogr B Biomed Sci Appl (1997) 0.84
Urinary excretion of dihydroxyphenylalanine and dopamine during alterations of dietary salt intake in humans. Clin Sci (Lond) (1989) 0.84
Deficient catecholamine release as the basis of orthostatic hypotension in pernicious anaemia. J Neurol Neurosurg Psychiatry (1982) 0.84
Plasma norepinephrine pharmacokinetics during mental challenge. Psychosom Med (1988) 0.84
Increased body fat mass and suppression of circulating leptin levels in response to hypersecretion of epinephrine in phenylethanolamine-N-methyltransferase (PNMT)-overexpressing mice. Endocrinology (2000) 0.83
Implications of plasma levels of catechols in the evaluation of sympathoadrenomedullary function. Am J Hypertens (1989) 0.83
Pharmacologic and tracer methods to study sympathetic function in primary hypertension. Clin Exp Hypertens A (1989) 0.82
Adrenomedullary function in patients with nonclassic congenital adrenal hyperplasia. Horm Metab Res (2010) 0.82
Dihydroxyphenylglycol and dihydroxymandelic acid during intravenous infusions of noradrenaline. Clin Sci (Lond) (1987) 0.82
Genotype-specific differences in the tumor metabolite profile of pheochromocytoma and paraganglioma using untargeted and targeted metabolomics. J Clin Endocrinol Metab (2014) 0.82
Norepinephrine spillover in forearm and subcutaneous adipose tissue before and after eating. J Clin Endocrinol Metab (1999) 0.82
Biochemical evidence of sympathetic denervation of the heart in pure autonomic failure. Clin Auton Res (1991) 0.82
Dosimetric estimates for clinical positron emission tomographic scanning after injection of [18F]-6-fluorodopamine. J Nucl Med (1991) 0.82
Successful chemotherapy of hepatic metastases in a case of succinate dehydrogenase subunit B-related paraganglioma. Endocrine (2009) 0.81
Hepatomesenteric release and removal of norepinephrine in swine. Am J Physiol (1995) 0.81
Different relationships of spillover to release of norepinephrine in human heart, kidneys, and forearm. Am J Physiol (1998) 0.81
Splanchnic circulation and regional sympathetic outflow during peroperative PEEP ventilation in humans. Br J Anaesth (1999) 0.81
Catecholamine metabolism. From molecular understanding to clinical diagnosis and treatment. Overview. Adv Pharmacol (1998) 0.81
Normalization of total body and regional sympathetic hyperactivity in heart failure after heart transplantation. J Heart Lung Transplant (1996) 0.81
Regional homovanillic acid production in humans. Life Sci (1993) 0.80
Vasopressin concentrations during alcohol withdrawal. Br J Addict (1985) 0.80
Differential effects of central and peripheral desipramine on sympathoadrenal function and heart rate in conscious rabbits. J Cardiovasc Pharmacol (1991) 0.80
Determination of differential activities of soluble and membrane-bound catechol-O-methyltransferase in tissues and erythrocytes. J Chromatogr B Biomed Sci Appl (1999) 0.80
Splanchnic and renal sympathetic activity in relation to hemodynamics during isoflurane administration in pigs. Anesth Analg (1995) 0.79
Analytical differences between the determination of plasma catecholamines by liquid chromatography with electrochemical detection and by radioenzymatic assay. J Chromatogr (1986) 0.79
Dopamine produced by the stomach may act as a paracrine/autocrine hormone in the rat. Neuroendocrinology (1998) 0.79
Hemodynamic, sympathetic and angiotensin II responses to PEEP ventilation before and during administration of isoflurane. Acta Anaesthesiol Scand (1997) 0.79
Is there a third peripheral catecholaminergic system? Endogenous dopamine as an autocrine/paracrine substance derived from plasma DOPA and inactivated by conjugation. Hypertens Res (1995) 0.79
Attenuated cardiac sympathetic responsiveness during dynamic exercise in patients with heart failure. Circulation (1997) 0.79
Beta-adrenoceptor responsiveness and plasma catecholamines as determinants of cardiovascular reactivity to mental stress. Clin Sci (Lond) (1985) 0.78
Chromogranin a expression in phaeochromocytomas associated with von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2. Horm Metab Res (2007) 0.78
Anti-tumor effects of peptide analogs targeting neuropeptide hormone receptors on mouse pheochromocytoma cells. Mol Cell Endocrinol (2012) 0.78
Effect of glipizide on dopamine synthesis, release and metabolism in PC12 cells. Eur J Pharmacol (2000) 0.78
Metabolic fate of injected radiolabelled dopamine and 2-fluorodopamine in rats. Neuropharmacology (1990) 0.78
Acidic dopamine metabolites are actively extruded from PC12 cells by a novel sulfonylurea-sensitive transporter. Naunyn Schmiedebergs Arch Pharmacol (2000) 0.78
Plasma 3,4-dihydroxyphenylalanine (dopa) and catecholamines in neuroblastoma or pheochromocytoma. Ann Intern Med (1986) 0.77
Growth hormone, vasopressin, cortisol, and catecholamine responses to insulin hypoglycemia in alcoholics. Alcohol Clin Exp Res (1984) 0.77
Adrenaline release by the human heart. Clin Exp Pharmacol Physiol (1991) 0.77
Effects of ethanol ingestion on thirst and fluid consumption in humans. Am J Physiol (1983) 0.77